Back to Search
Start Over
279MO Three-year survival, safety and extended long-term survivor (eLTS) analysis from the phase III TOPAZ-1 study of durvalumab (D) plus chemotherapy in biliary tract cancer (BTC).
- Source :
-
Annals of Oncology . 2024 Supplement 1, Vol. 35, pS117-S117. 1p. - Publication Year :
- 2024
- Subjects :
- *CANCER chemotherapy
BILIARY tract cancer
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 35
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 178046093
- Full Text :
- https://doi.org/10.1016/j.annonc.2024.05.285